Drug Metabolism and Bioanalysis Letters
Formerly: Drug Metabolism Letters
Volume 15, 3 Issues, 2022
ISSN: 2949-6829 (Online)
ISSN: 2949-6810 (Print)
This journal supports open access
ISSN: 2949-6829 (Online)
ISSN: 2949-6810 (Print)
This journal supports open access
Contents
Drug Metabolism Letters , Volume 1 - Number 1
Effect of Common NAT2 Variant Alleles in the Acetylation of the Major Clonazepam Metabolite, 7-minoclonazepam
, 1(1): 3 - 5M. Olivera, C. Martinez, G. Gervasini, J. A. Carrillo, S. Ramos, J. Benitez, E. Garcia-Martin and J. A. G. Agundez
DOI: 10.2174/187231207779814283
Verapamil, but not Probenecid, Co-Administration Can Convert Desloratadine to a Sedating Antihistamine in Mice
, 1(1): 7 - 11Anand Katta, Mugunthu Dhananjeyan, Crystal Bykowski, Paul Erhardt, Miles Hacker, Donald B. White and Kenneth Bachmann
DOI: 10.2174/187231207779814391
In Vitro Inhibition of Rat CYP1A1 and CYP1A2 by Piceatannol, a Hydroxylated Metabolite of trans-Resveratrol
, 1(1): 13 - 16Thomas K. H. Chang, Jie Chen and Chia-Ting Yu
DOI: 10.2174/187231207779814337
Comparison of Paraben Stability in Human and Rat Skin
, 1(1): 17 - 21Heather M. Harville, Richard Voorman and Jeffery J. Prusakiewicz
DOI: 10.2174/187231207779814300
ABCB1, SLCO1B1 and UGT1A1 Gene Polymorphisms Are Associated with Toxicity Line Irinotecan
, 1(1): 23 - 30Katrin E. Rhodes, Wu Zhang, Dongyun Yang, Oliver A. Press, Michael Gordon, Daniel Vallbohmer, Anne M. Schultheis, Georg Lurje, Robert D. Ladner, William Fazzone, Heinz-Josef Lenz and Syma Iqbal
DOI: 10.2174/187231207779814328
Drug Confinement and Delivery in Ceramic Implants
, 1(1): 37 - 40Maria Vallet-Regi, Francisco Balas, Montserrat Colilla and Miguel Manzano
DOI: 10.2174/187231207779814382
Application of Pharmacogenomics in Drug Discovery and Development:Correlations Between Transcriptional Modulation and Preclinical Safety Observations
, 1(1): 41 - 48Lilian G. Yengi, Qian Xiang, Li Shen, Appavu Chandrasekaran, John Kao and JoAnn Scatina
DOI: 10.2174/187231207779814274
A Role for Lysosomal Phospholipase A2 in Drug Induced Phospholipidosis
, 1(1): 49 - 53Akira Abe, Miki Hiraoka and James A. Shayman
DOI: 10.2174/187231207779814292
A Unique Example of Drug Metabolism: Tetra- and Penta-Oxygenation Reactions of Capravirine in Rats, Dogs and Humans
, 1(1): 61 - 65Hai-Zhi Bu, William F. Pool, Ellen Y. Wu and Bhasker V. Shetty
DOI: 10.2174/187231207779814373
Metabolic Stability Screen for Drug Discovery Using Cassette Analysis and Column Switching
, 1(1): 67 - 72Jason S. Halladay, Susan Wong, Sharmin M. Jaffer, Achintya K. Sinhababu and S. Cyrus Khojasteh-Bakht
DOI: 10.2174/187231207779814364
Structures of Various Cytochromes c Evaluated from the Redox Behaviors Using the Optically Active Co(III) Complex-Modified Au Electrode
, 1(1): 73 - 75Isao Takahashi, Chika Nishijima, Tomohiko Inomata, Yasuhiro Funahashi, Tomohiro Ozawa and Hideki Masuda
DOI: 10.2174/187231207779814265
Effects of Propofol Analogs on Glucuronidation of Propofol, an Anesthetic Drug, by Human Liver Microsomes
, 1(1): 77 - 79Makiko Shimizu, Yoshiaki Matsumoto and Hiroshi Yamazaki
DOI: 10.2174/187231207779814355
Drug Interactions of Tipranavir, a New HIV Protease Inhibitor
, 1(1): 81 - 84Judit Morello, Sonia Rodriguez-Novoa, Inmaculada Jimenez-Nacher and Vincent Soriano
DOI: 10.2174/187231207779814256
Editor-in-Chief
Zhiyang Zhao
Alliance Pharma
Malvern, PA
(USA)
Biography
Alliance Pharma
Malvern, PA
Biography
Biography of Zhiyang Zhao
Zhiyang Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Tech, Blacksburg, Virginia, USA. Dr. Zhao’s biopharmaceutical/pharmaceutical work experience encompasses over 25 years of research in metabolic and pharmacokinetic properties of compounds for drug discovery and development at Pfizer, GlaxoSmithKline and Amgen. Currently, Dr. Zhao serves as Chief Scientific Officer (CSO) at Alliance Pharma, Inc. and is appointed as an adjunct professor at the School of Pharmacy, the University of North Carolina at Chapel Hill. Dr. Zhao has published over 50 peer-reviewed original research papers and patents in the areas of new drug targets, drug metabolism, pharmacokinetics, and toxicology.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Webmaster Contact: info@benthamscience.net